chr7-151622469-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_016203.4(PRKAG2):​c.754+9600T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.421 in 152,094 control chromosomes in the GnomAD database, including 14,011 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.42 ( 14011 hom., cov: 32)

Consequence

PRKAG2
NM_016203.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.361

Publications

10 publications found
Variant links:
Genes affected
PRKAG2 (HGNC:9386): (protein kinase AMP-activated non-catalytic subunit gamma 2) AMP-activated protein kinase (AMPK) is a heterotrimeric protein composed of a catalytic alpha subunit, a noncatalytic beta subunit, and a noncatalytic regulatory gamma subunit. Various forms of each of these subunits exist, encoded by different genes. AMPK is an important energy-sensing enzyme that monitors cellular energy status and functions by inactivating key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This gene is a member of the AMPK gamma subunit family. Mutations in this gene have been associated with Wolff-Parkinson-White syndrome, familial hypertrophic cardiomyopathy, and glycogen storage disease of the heart. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jan 2015]
PRKAG2 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • PRKAG2-related cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • lethal congenital glycogen storage disease of heart
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, PanelApp Australia
  • Wolff-Parkinson-White syndrome
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.479 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016203.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAG2
NM_016203.4
MANE Select
c.754+9600T>C
intron
N/ANP_057287.2
PRKAG2
NM_001407021.1
c.754+9600T>C
intron
N/ANP_001393950.1
PRKAG2
NM_001407022.1
c.754+9600T>C
intron
N/ANP_001393951.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAG2
ENST00000287878.9
TSL:1 MANE Select
c.754+9600T>C
intron
N/AENSP00000287878.3Q9UGJ0-1
PRKAG2
ENST00000392801.6
TSL:1
c.622+9600T>C
intron
N/AENSP00000376549.2Q9UGJ0-3
PRKAG2
ENST00000418337.6
TSL:1
c.31+9600T>C
intron
N/AENSP00000387386.2Q9UGJ0-2

Frequencies

GnomAD3 genomes
AF:
0.421
AC:
63981
AN:
151976
Hom.:
14014
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.356
Gnomad AMI
AF:
0.686
Gnomad AMR
AF:
0.395
Gnomad ASJ
AF:
0.397
Gnomad EAS
AF:
0.116
Gnomad SAS
AF:
0.391
Gnomad FIN
AF:
0.465
Gnomad MID
AF:
0.411
Gnomad NFE
AF:
0.483
Gnomad OTH
AF:
0.402
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.421
AC:
63992
AN:
152094
Hom.:
14011
Cov.:
32
AF XY:
0.417
AC XY:
30966
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.355
AC:
14735
AN:
41490
American (AMR)
AF:
0.395
AC:
6028
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.397
AC:
1376
AN:
3470
East Asian (EAS)
AF:
0.116
AC:
602
AN:
5188
South Asian (SAS)
AF:
0.391
AC:
1881
AN:
4814
European-Finnish (FIN)
AF:
0.465
AC:
4910
AN:
10554
Middle Eastern (MID)
AF:
0.401
AC:
118
AN:
294
European-Non Finnish (NFE)
AF:
0.483
AC:
32865
AN:
67988
Other (OTH)
AF:
0.404
AC:
853
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1858
3716
5575
7433
9291
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
604
1208
1812
2416
3020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.459
Hom.:
20754
Bravo
AF:
0.413
Asia WGS
AF:
0.251
AC:
873
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.83
DANN
Benign
0.82
PhyloP100
0.36
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6464156; hg19: chr7-151319555; API